絞り込み

16532

広告

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

著者 D'Agostino M , Gazzera G , Cetani G , Bringhen S , Boccadoro M , Gay F
Curr Med Chem.2018 May 13 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (65view , 0users)

Full Text Sources

Survival of multiple myeloma patients has considerably improved in the last decades thanks to the introduction of many new drugs, including immunomodulatory agents, proteasome inhibitors and, more recently, monoclonal antibodies.
PMID: 29756564 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード